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Abstract
Background: HCV transmission is closely associated with drug-trafficking routes in China. However, the transmission route
of HCV in Eastern China remains unclear. Here, we investigate the role of Zhenjiang city of Jiangsu province, an important
transportation hub linking Shanghai with other regions of China, in HCV transmission.
Methodology/Principal Findings: A total of 141 whole blood samples were collected from injection drug users (IDUs) in
Zhenjiang and then tested for HCV infection. Of them, 115 HCV positive plasmas were subjected to RNA extraction, RT-PCR
amplification, and sequencing. The subtype characterization and the evolutionary origin of HCV strains circulating in
Zhenjiang were determined using polygenetic or phylogeographic analyses. Seven HCV subtypes 1b, 2a, 3a, 3b, 6a, 6e and
6n were detected among Zhenjiang IDUs, showing a complex HCV epidemic. The most predominant subtypes were 3a
(38%) and 1b (26.8%). Among these subtypes, subtypes 3b, 6n and 6e originated from Southwestern China (i.e., Yunnan
and/or Guangxi), subtypes 2a and 6a from Southern China (i.e., Guangdong), subtype 1b from Central (i.e., Henan) and
Northwestern (i.e., Xinjiang) China, and subtype 3a from Southwestern (i.e., Yunnan) and Northwestern (i.e., Xinjiang) China.
From Zhenjiang, subtypes 1b and 2a were further spread to Eastern (i.e., Shanghai) and Northern (i.e., Beijing) China,
respectively.
Conclusions/Significance: The mixing of seven HCV subtypes in Zhenjiang from all quarters of China indicates that as an
important middle station, Zhenjiang plays a crucial role in HCV transmission, just as it is important in population migration
between other regions of China and Eastern China.
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Introduction
Hepatitis C virus (HCV) is an enveloped virus and contains a
single-stranded positive RNA genome of approximately 9.6 kb in
length. HCV belongs to the Hepacivirus genus of the Flaviviridae
family [1] and is a main cause for chronic liver disease [2]. HCV
infection is a serious global public health problem, with
approximately 200 million people estimated to be living with
HCV worldwide [3,4]. In China, approximately 38 million
peoples, with a prevalence of around 3.2% of China’s population,
are estimated to be infected with HCV (http://www.cfhpc.org/
detail.asp? id=283). HCV is transmitted predominantly via
injection drug use (IDU), blood transfusion, sexual contact, etc.
[3,5]. Since 1990s when China started to carry out the strict
management of blood products and mandatory screening for
various blood viruses, HCV infection through contaminated blood
products decreased dramatically [6]. Recently, high proportions
(15.6–98.7%) of injection drug users (IDUs) were reported to be
HCV positive [7,8,9,10,11,12]. This indicates that IDU has
become the predominant mode of HCV transmission in China
[13,14].
HCV has been classified into six genotypes and a large number
of subtypes based on their genomic sequences [15,16,17].
Although HCV genotypes 1, 2 and 3 are globally prevalent, the
prevalence of other genotypes appears to be segregation of
subtypes between different geographic groups [2,3,14]. For
example, HCV genotype 4 is predominant in Middle East and
Northern Africa, and genotype 5 in Southern Africa. For genotype
6, it is geographically predominant HCV genotype in Southeast-
ern Asia [2,3,14].
In China, at least 4 genotypes (1, 2, 3, and 6) are found, and the
major prevalent subtype is 1b that accounts for about 73% of all
HCV infection. Subtype 2a is the second prevalent subtype,
accounting for 14%. Genotypes 3 and 6 are geographically
predominant HCV genotypes circulating in Southwestern China
(e.g. Yunnan) [2,8]. In addition, subtypes 1a, 1b, 3a, 3b, 6a, 6n,
and 6u are circulating among IDUs, with the most predominant
subtype of 6a [8,14].
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River Delta and is one of the most important transportation
stations linking Shanghai with other regions of China. Currently,
approximately 2214 to 5535 IDUs are estimated to live in
Zhenjiang [18]. Previous studies have shown that several HIV-1
subtypes/CRFs are transmitted from Yunnan, a southwestern
province, to other regions of China via drug-trafficking routes, in
which Jiangsu serves an important station for the spread of HIV-1
to Northern China (Reviewed in Ref. [13]). The investigation of
HCV subtype characterization among IDUs in Zhenjiang will
help to understand the spreading pattern of HCV infection in
Eastern China. Here, we report the HCV genotype distribution
among IDUs in Zhenjiang and shed light into the phylogenetic
relationship of HCV between Zhenjiang and other regions of
China.
Results
The amplification of HCV NS5B and C/E2 genomic
fragments
Among 141 IDUs who are local residents in Zhenjiang, 115
appear to be HCV positive. The HCV prevalence among this
IDUs cohort is 82% (115/141, 95% confidence interval (CI),
88.3%–75.7%), close to the positive ratio (75.1%, 232/309)
reported in a recent epidemiological investigation on Zhenjiang
IDUs [18]. From 115 positive samples, 65 (56.5%) NS5B
fragments (about 1042 bp) and 37 (32.2%) C/E2 fragments (about
1241 bp) were successfully amplified and sequenced. As a result,
there are 31 strains containing both NS5B and C/E2 sequences,
and 40 strains containing one of both sequences. The failure in the
amplification of viral genome in other samples may be due to two
days exposure of these samples at room temperature before store
at 280uC or low viral loads.
Prevalent HCV subtypes among IDUs in Zhenjiang,
Jiangsu, China
The phylogenetic trees of 65 NS5B and 37 C/E2 fragments are
shown in Figures 1 and S1, respectively. According to the NS5B
tree, 7 HCV subtypes including 1b, 2a, 3a, 3b, 6a, 6e and 6n are
identified among Zhenjiang IDUs. Except subtype 2a, all subtypes
identified in NS5B tree are confirmed in C/E2 tree (Fig. S1). The
subtype proportions are well consistent between NS5B and C/E2
fragments (Table 1). The most predominant subtypes among these
IDUs are 3a and 1b, both of which account for 38.0% (95% CI,
49.3%–26.7%) and 26.8% (95% CI, 37.1%–16.5%) of all 71
strains (Table 1).
Comparison of HCV subtype distributions among IDUs
between Zhenjiang and other regions of China
HCV transmission among IDUs is associated with various drug-
trafficking routes [8,9,10,14,19]. To investigate whether there
is a potential association in HCV transmission among IDUs
between Zhenjiang and other regions of China, we collected the
distribution information of HCV genotypes from several available
provinces of China by the public reference database (PubMed)
[8,9,10,20,21,22,23,24] and compared them with the distribution of
HCV subtypes in Zhenjiang. Because of the information unavail-
able on PubMed, several surrounding provinces such as Anhui,
Zhejiang, Shandong and Shanghai are not included in the
comparison. Figure 2 shows the HCV subtype distributions among
IDUs in Zhenjiang of Jiangsu province and other provinces/regions
(including Yunnan, Guangxi, Hubei, Xinjiang, Hong Kong, and
Taiwan). One peak in HCV subtype distributions is observed to
associate with various provinces/regions. It appears in subtype 6a
that is the most predominant HCV subtype circulating in Hong
Kong, Hubei and Guangxi. In Zhenjiang, three top predominant
subtypes are 3a, 1b and 3b. The three top predominant subtypes
observed in Zhenjiang are also the most predominant subtypes in
Xinjiang and Yunnan (Fig. 2). Although the patterns of HCV
subtype distributions are different between the three regions, the
consistence in three top predominant subtypes suggests a potential
association of Zhenjiang with Xinjiang and Yunnan in the
transmission of at least subtypes 1b, 3a, and 3b (Fig. 2).
HCV subtypes circulating among Zhenjiang IDUs had
complex phylogenetic origins
To investigate the evolutionary origin of HCV subtypes
circulating in Zhenjiang, the phylogenetic trees of NS5B (Fig. 3A)
and C/E2 fragments (Fig. S2A) were constructed with the
sequences from Zhenjiang and other regions of China. Because
of few corresponding sequences available from Database, no
Taiwan sequence was included in the phylogenetic analyses. In
both trees, all subtypes form well-supported clades (with bootstrap
values of $99%). In subtype 6a clade, all Zhenjiang strains are
Table 1. The distribution of genotypes of Hepatitis C Virus based on NS5B and C/E2 segments.
Genomic
fragment HCV subtypes
Total
(n)
1b 2a 3a 3b 6a 6e 6n
NS5B 17(26.2%) 1(1.5%) 24(36.9%) 9(13.8%) 6(9.2%) 6(9.2%) 2(3.1%) 65
C/E2 14(37.8%) 0(0%) 14(37.8%) 3(8.1%) 1(2.7%) 4(10.8%) 1(2.7%) 37
Total
a 19 (26.8%)
(37.1%–16.5%)
1(1.4%)
(8%–0%)
27(38.0%)
(49.3%–26.7%)
10(14.1%)
(22.2%–6.0%)
6(8.5%)
(15.0%–2.0%)
6(8.5%)
(15.0%–2.0%)
2(2.8%)
(10%–0%)
71
aThe 95% confidence interval of the distribution ratio (P) of each genotype is shown at the bottom of the blank. The interval estimation was performed using normal
theory method based on normal distribution (nP(1-P) $5, i.e. subtype 1b, 3a, 3b, 6a and 6e) and exact method based on binomial distribution (nP(1-P),5, i.e. subtype
2a and 6n).
doi:10.1371/journal.pone.0016817.t001
Figure 1. Phylogenetic tree of NS5B fragments of HCV strains isolated from Zhenjiang. The sequences correspond to nucleotides 8262–
9312 in HCV H77 genome (NC-004102). Only bootstrap values .75% are shown. The sequences from Zhenjiang IDUs are labeled by red solid
triangles.
doi:10.1371/journal.pone.0016817.g001
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regions of China, Guangdong and Hong Kong, indicating that 6a
subtype circulating among Zhenjiang IDUs might originate from
Southeastern China. In the clades of 3b and 6n, all Zhenjiang
strains closely cluster within the strains from Yunnan, indicating
that 3b and 6n subtypes are introduced into Zhenjiang from
Southwestern China. In addition, 6e subtype strains from
Zhenjiang cluster with one sequence from Guangxi, implying an
evolutionary association in subtype 6e between Zhenjiang and
Southwestern China. Intriguingly, in the 2a clade of NS5B tree,
one sequence from Guangdong is placed at the root, and one
Zhenjiang sequence (09CNJSZJ249) cluster between the strains
from Southern China (i.e. Guangdong) and from Central and
Northeastern China (Fig. 3A). This implies that Zhenjiang might
be a middle station for HCV subtype 2a transmission from
Southern China to Central and Northeastern China.
Different from the clades of 2a, 3b, 6n and 6e subtypes, the 1b and
3a clades contain two or more than two sub-clusters. In the 1b clade,
the sequences from Zhenjiang are dispersed together with strains from
Northeastern, Northern, Central, Eastern, Southeastern and South-
western China, supporting the nationwide prevalence of subtype 1b.
Because of lack of NS5B sequences from northwestern province
Xinjiang, we further constructed a 1b sub-tree using the C/E2
sequences from whole China (Fig. S2B). Consistent with the NS5B
tree, strains isolated in Zhenjiang are also dispersed together with the
strains from whole China in C/E2 tree. In particular, one well-
supported sub-cluster shows a close cluster of Zhenjiang HCV strains
with the strains from Xinjiang (Fig. S2B). These results suggest that
Zhenjiang might be one of the most important mixing places of HCV
1b strains from other regions of China.
With respect to the 3a subtypes, both NS5B and C/E2 trees show
that the strains from Zhenjiang are dispersed into two different sub-
clusters. One sub-cluster includes HCV strains from Yunnan and
another includes strains from Xinjiang (Figs. 3C and S2C). This
suggests that 3a strains circulating in Zhenjiang are phylogenetically
related to Yunnan and Xinjiang strains (Figs. 3C and S2C).
Migration routes of HCV 1b and 3a in China
To further investigate the evolutionary origins of HCV 1b and
3a strains circulating in Zhenjiang, we performed phylogeographic
analyses using recently developed Bayesian phylogeographic
inference framework. The Maximum clade credibility (MCC) tree
of HCV 1b strains shows that the most recent common ancestor
(tMRCA) of China 1b strains originates in Henan, a central
province of China, and except one strain from Hubei province all
China 1b strains form four clades (Fig. 4). The strains from
Zhenjiang form three sub-clusters and are dispersed within three
clades, clearly indicating that Zhenjiang 1b strains have three
independent origins. Among three Zhenjiang sub-clusters, two
originate from Henan and another originates from Xinjiang.
Intriguingly, one strain from Shanghai clusters within one Henan-
originated Zhenjiang sub-cluster (Fig. 4), indicating a spread of
HCV 1b strains from Zhenjiang to Shanghai. This suggests that
Zhenjiang may serve as a middle station during the spread of
HCV 1b strains from Henan to Shanghai.
The tree of HCV 3a strains shows that all 3a strains form three
clades with a common origin in Xinjiang (Fig. 5). They include
two Xinjiang clades and one Yunnan clade (including strains from
Yunnan and Guangxi). Similar to subtype 1b, 3a strains from
Zhenjiang are also dispersed within three clades, indicating three
independent origins. Two Zhenjiang sub-clusters (one of them
only included one sequence) closely cluster within the Xinjiang
clades, indicating origins from Xinjiang, and another clusters
within the Yunnan clade, implying an origin from Southwestern
China.
Discussion
Currently, 4 HCV genotypes (1, 2, 3 and 6) including more than
13 subtypes are prevalent in China, and the two most
predominant subtypes are 1b and 2a, both which result in a
nation-wide prevalence [2,25]. HCV prevalence has been
demonstrated to be segregation of subtypes between geographic
groups [2,3,14]. Among IDUs, the northwestern frontier province
Xinjiang and southwestern frontier province Yunnan have the
most complex HCV subtype distributions of more than 4 subtypes
[8,10,20,21,25].
In this study, we found that seven HCV subtypes including 1b,
2a, 3a, 3b, 6a, 6e and 6n are circulating among IDUs in Zhenjiang
(Table 1). The complex HCV subtype distribution appearing
among IDUs in Zhenjiang implies the importance of Zhenjiang in
Figure 2. Comparison of HCV subtype distributions among IDUs between Zhenjiang and other regions of China.
doi:10.1371/journal.pone.0016817.g002
Complex HCV Subtype Prevalence in Zhenjiang
PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e16817HCV transmission and a complex origination of Zhenjiang strains.
Comparison with other regions shows that Zhenjiang has a unique
HCV subtype distribution pattern, in which subtypes 3a, 1b and
3b are the three top predominant subtypes, similar to those
observed in Xinjiang and Yunnan provinces (Fig. 2). This suggests
a close association of Zhenjiang with Xinjiang and Yunnan in
HCV transmission, which is supported by further phylogenetic
analyses.
Based on the phylogenetic relationship, we investigated the
origin of HCV strains circulating among Zhenjiang IDUs. The 3b
and 6n strains from Zhenjiang closely cluster with the strains from
Yunnan, and Zhenjiang 6e strains closely cluster with the strains
from Guangxi (Figs. 3A and S2A), suggesting that these strains are
transmitted to Zhenjiang from Southwestern China (Yunnan and/
or Guangxi). The 6a strains from Zhenjiang are dispersed among
the strains from Guangdong and Hong kong, indicating an
origination from Southeastern China. The subtype 2a clade is a
monophylogenetic clade, in which one strain from Guangdong is
located at the outermost phylogenetic branch. This suggests an
initial origin of Zhenjiang 2a strains from Guangdong. Intrigu-
ingly, the 2a clade is divided by the Zhenjiang strain
09CNJSZJ249 into two geographic groups, the Southern China
Figure 3. The NS5B phylogenetic relationship of HCV strains isolated from Zhenjiang IDUs with those from other regions of China.
Please see Figure 6 for the location of other regions in China and Figure 1 for other details. (A) The whole phylogenetic tree. (B) The sub-tree of HCV
subtype 1b strains. (C) The sub-tree of HCV subtype 3a strains.
doi:10.1371/journal.pone.0016817.g003
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supports a transmission route of HCV along the coastal cities from
Southern China to Central and North China via Zhenjiang [13].
The two most prevalent subtypes among Zhenjiang IDUs are 3a
and 1b. Both subtypes are also predominant in Xinjiang and
Yunnan (Fig. 2) [14,25]. Because 1b is the nationwide prevalent
subtype in China, high proportion of 1b prevalence among
Zhenjiang IDUs is unsurprising. In the phylogenetic trees, the 1b
strains isolated in Zhenjiang are dispersed together with the strains
from Northwestern, Northeastern, Northern, Central, Eastern,
Southeastern and Southwestern China (Figs. 3B and S2B),
suggesting the genetically association of Zhenjiang strains with
the strains from other regions. Further phylogeographic analysis
shows that subtype 1b strains are transmitted to Zhenjiang from
Henan and Xinjiang via three independent transmission routes
and from Zhenjiang one Henan-originated strain is further
transmitted eastward to Shanghai (Fig. 4). These results suggest
that Zhenjiang might be a middle station in transmission of HCV
subtype 1b in China. For 3a subtype, two obvious sub-clusters
show that Zhenjiang strains are related to two sub-groups from
Xinjiang and Yunnan (Figs. 3C and S2C). Further phylogeo-
graphic analysis shows that 3a strains in Zhenjiang are transmitted
from Xinjiang and Yunnan (Fig. 5).
In order to well show the association of Zhenjiang in HCV
transmission with other regions of China, we summarize our results
in Figure 6. Among seven HCV subtypes circulating among
Zhenjiang IDUs, subtypes 3b, 6n and 6e originate from
Southwestern China (i.e. Yunnan and/or Guangxi), subtypes 2a
and 6a from Southern China (i.e. Guangdong and/or Hong Kong),
subtype 1b from Central (i.e. Henan) and Northwestern (i.e.
Xinjiang) China, and subtype 3a from Southwestern (i.e. Yunnan)
and Northwestern (i.e. Xinjiang) China. From Zhenjiang, subtypes
1b and 2a further spread to Eastern (i.e. Shanghai) and Northern
(e.g. Beijing and Liaoning) China, respectively (Fig. 6). These
Figure 4. Maximum clade credibility tree of the HCV 1b sequences. The tree was reconstructed based on the genomic region (H77 1341–
1835 nt) located in C/E2. Ancestral geographic states were reconstructed using Bayesian phylogeographic inference framework implemented in the
BEAST v1.5.4 package. The tree branches are colored according to their respective geographical locations. The time scale is shown at the bottom.
doi:10.1371/journal.pone.0016817.g004
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possible by serving as a middle station. Because Zhenjiang is an
important transportation node connecting other regions of China
and Eastern China (e.g. Shanghai), the mixing of seven HCV
subtypes inZhenjiangmaybeassociated withlarge-scale population
migration. In addition, we believe that other regional central cities
(e.g. Nanjing, Zhengzhou, etc.) in the transportation networks
should also play crucial roles in HCV transmission in China.
On the other hand, four HCV subtypes (3a, 3b, 6n and 6e) are
demonstrated to spread to Zhenjiang from Yunnan, and another
two subtypes (1b and 3a) from Xinjiang (Figs. 4 and 5), suggesting
that both Yunnan and Xinjiang play important roles in HCV
transmission. In fact, Yunnan that borders the heroin-producing
areas (Golden Triangle) is the most important transfer station for
drug-trafficking from ‘Golden Triangle’ to other regions of China
[26,27]. Its importance in HIV-1 transmission is well known. Along
the drug-trafficking route from Golden Triangle to Yunnan, HIV-1
subtypes B’ and C are demonstrated to be introduced into Yunnan
from ThailandandIndia,respectively[26,27].Theco-circulationof
B’ and C among IDUs leads to the generation of two closely related
CRFs (07_BC and 08_BC), both of which further spread to other
regions of China along different drug-trafficking routes [28,29].
Xinjiang borders another drug-producing area (Golden Crescent)
and is another most important transfer stationfordrug-trafficking to
China (Fig. 6) [30]. Up to now, however, there is less report about
the role that Xinjiang plays in HIV-1 transmission in China. HCV
has similar transmission routes to HIV. Our finding suggests that
unlike previously thought, Xinjiang may play an important role in
HCV transmission, as well as HIV transmission.
Since the sample size of Zhenjiang IDUs is relatively small and
the related data of other regions of China in PubMed is limited,
this study is unable to provide the most comprehensive scenario
about HCV transmission in China. To deeply understand HCV
transmission/migration pattern among IDUs in China, large-scale
molecular epidemiological investigations need to be conducted
among IDUs population.
Materials and Methods
Ethics Statement
This study was done according to the Helsinki II Declaration
and was approved by the medical ethics committee of Zhenjiang
Center of Disease Control and Prevention (CDC). All participants
were voluntary in this study and written informed consents were
obtained from them.
Samples, HCV RNA extraction, RT-PCR amplification
A total of 141 whole blood samples (about 5 mL) were collected
from approximate 630 IDUs enrolled in Zhenjiang Methadone
Treatment Center and Jiangsu Women’s Re-education through
Figure 5. Maximum clade credibility tree of the HCV 3a sequences. The tree was reconstructed based on the genomic region (H77 1356–
1826 nt) located in C/E2. Please see Figure 4 for other details.
doi:10.1371/journal.pone.0016817.g005
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during 2009. Both institutions are located in Zhenjiang city of
Jiangsu province and all participants are local residents. The
information about the gender and the age of these participants in
this study was not collected. The samples were transported from
the scene to Zhenjiang CDC for detection of antibodies to HCV.
However, because of neglect of official duty in preservation and/
or transportation of samples, some samples were exposed at room
temperature two days before store at 280uC, which may result in
a low amplification efficiency of viral genome. Plasma was
separated by centrifugation and anti-HCV antibodies were
determined using an enzyme immunoassay kit (Wantai Biotech-
nology Ltd., Beijing, China). The RNA was extracted from
200 ml of HCV-positive plasma with the MiniBEST Viral RNA/
DNA Extraction Kit Ver 4.0 (TaKaRa Biotechnology Co. Ltd.,
Dalian, China). The cDNA was synthesized using the TaKaRa
RNA PCR kit (AMV) Ver.3.0 and then was subjected to the
nested PCR for amplifying the C/E2 and the NS5B regions of
HCV genome. The first PCR reactions were performed using the
same kit as the cDNA synthesis, and the second PCR reactions
were performed using TaKaRa PCR Amplification Kit (Ta-
KaRa, Dalian, China). The primer pairs used in the nested PCR
were modified from the previous paper. The information of
primers and the reaction programs are shown in Table S1. After
the identification using 1% agarose gel, the amplified products
were sent to Shanghai Invitrogen Biotechnology Co., LTD. for
sequencing.
HCV genotyping and phylogenetic analyses
The sequences obtained here were aligned together with HCV
subtype reference sequences using CLUSTAL W program
implemented in MEGA 4.0. HCV subtype reference sequences
were downloaded from the Los Alamos HCV database (http://
hcv.lanl.gov/content/sequence/HCV/ToolsOutline.html). HCV
sequences from other regions of China were obtained from refs
[8,9,10,20,21,22,23,24]. The phylogenetic trees of two HCV
genomic fragments NS5B and C/E2 were constructed using NJ
(neighbor-joining) method (MEGA 4.0) [31], and the reliability of
the trees were evaluated by the bootstrap method with 1,000
replications.
Phylogeographic analyses of HCV 1b and 3a
To investigate the possible geographic origins of HCV 1b and
3a in Zhenjiang, all HCV 1b and HCV 3a nucleotide sequences
with known sampling years and locations in China were collected
from the HCV Sequence Database. Each sequence was assigned a
character state reflecting its sampling location. The maximum
clade credibility tree was constructed using a MCMC (Markov
Chain Monte Carlo) method implemented in the BEAST v1.5.4
package [32]. Ancestral geographic states were inferred using a
geographically explicit Bayesian MCMC method implemented in
BEAST v1.5.4 package [32,33]. MCMC analysis was run for 20
million generations, with sampling every 10,000 generations. The
initial 25% of the samples were discarded as burn-in, leaving 1501
trees per run, when we summarized the trees using TreeAnnotator
Figure 6. Potential migration routes of several HCV subtypes in China. The arrows represent the potential migration routes of HCV. XJ:
Xinjiang; LN: Liaoning; SD: Shandong; HN: Henan; JS: Jiangsu; SH: Shanghai; YN: Yunnan; GX: Guangxi; GD: Guangdong; HK: Hong Kong. Because few
corresponding sequences from Taiwan are available for phylogenetic analyses, this Figure does not include Taiwan.
doi:10.1371/journal.pone.0016817.g006
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corresponding sequences from other China regions are very
limited, we did not perform the phylogeographic analyses of other
HCV subtypes.
Nucleotide sequence accession numbers
The HCV NS5B and C/E2 sequences reported in this article
are available in GenBank under accession numbers of HQ318826-
HQ318927.
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